Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

 

financial results 260x173 homepageFirst Nine Months of 2019 Financial Results

Genmab reported its First Nine Months of 2019 financial results and held an investor call on November 6. Click here to download the report, click here to listen to the archived webcast, click here to download the call as an MP3 and click here to view the webcast slides.

 

join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.    

 

 

Genmab 20 Years LogoCelebrating 20 Years

Genmab celebrates its 20th anniversary this year. We asked employees and external stakeholders for their perspectives on Genmab. Click here to watch the video and find out what they said.